Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil

References

• Levin A, Stevens PE, Bilous RW. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1.
   Web of Science ®Google Scholar
• Sesso RC, Lopes AA, Thomé FS, et al. Brazilian Chronic Dialysis Survey 2013 – trend analysis between 2011 and 2013. J Bras Nefrol. 2014;36(4):476.
   PubMedGoogle Scholar
• Romão Junior JE. Doença renal crônica: definição epidemiologia e classificação. J Bras Nefrol. 2004;26(3, suppl. 1):1.
   Google Scholar
• Opelz G, Döhler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation. 2007;84(2):137–143.
   PubMed Web of Science ®Google Scholar
• Machnicki G, Seriai L, Schnitzler MA. Economics of transplantation: a review of the literature. Transplant Rev. 2006;20(2):61–75.
   Google Scholar
• Álvares J, Cesar CC, Acurcio FA, et al. Quality of life of patients in renal replacement therapy in Brazil: comparison of treatment modalities. Qual Life Res. 2012;21(6):983–991.
   PubMed Web of Science ®Google Scholar
• Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605–612.
   PubMed Web of Science ®Google Scholar
• Port FK, Dykstra DM, Merion RM, et al. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant. 2005;5(4p2):843–849.
   PubMed Web of Science ®Google Scholar
• Gómez MP, Pérez B, Manyalich M. International registry in organ donation and transplantation – 2013. Transplant Proc. 2014;46(4):1044–1048.
   PubMed Web of Science ®Google Scholar
• Medina-Pestana JO, Vaz ML, Park SI, et al. Organ transplantation in Brazil in the year 2002. Transplant Proc. 2004;36(4):799–801.
   PubMed Web of Science ®Google Scholar
• BRASIL. Portaria SAS/MS nº 221 de 01 de abril de 2002 da Secretaria de Atenção à Saúde do Ministério da Saúde. Aprova a Diretrizes Clínicas e Protocolos Terapêuticos de Medicamentos Excepcionais e de Alto Custo no SUS. Transplantes Renais. In: Saúde Md, ed. Diário Oficial da União Republica Federativa do Brasil, Imprensa Nacional Brasília - DF. Nº 62 - DOU - 2/4/2002. [cited 2015 Oct 2]. http://189.28.128.100/portal_transplante/legislacaosnt/portaria_SAS_n_221_de_01_de_abril_de_2002.pdf
   Google Scholar
• BRASIL. Portaria SAS/MS nº 666, de 17 de julho de 2012 da Secretaria de Atenção à Saúde do Ministério da Saúde. Aprova a Diretrizes Clínicas e Protocolos Terapêuticos de Medicamentos Excepcionais e de Alto Custo no SUS. Transplantes Renais [Internet]. In: Saúde Md, ed. Diário Oficial da União, República Federativa do Brasil Imprensa Nacional Brasília - DF .Nº 140 - DOU - 20/07/12 - seção 1 - p.69 2012. ftp://ftp.saude.sp.gov.br/ftpsessp/bibliote/informe_eletronico/2012/iels.jul.12/Iels136/U_PT-MS-SAS-666_170712.pdf
   Google Scholar
• Medina-Pestana JO, Galante NZ, Tedesco-Silva Jr. H, et al. Kidney transplantation in Brazil and its geographic disparity. J Bras Nefrol. 2011;33(4):472–484.
   PubMedGoogle Scholar
• Garcia SC, Lopes L, Schott KL, et al.Ciclosporina A e tacrolimus: uma revisão. Jornal Brasileiro de Patologia E Medicina Laboratorial. 2004;40(6):393–401.
   Google Scholar
• Liu JY, You RX, Guo M, et al. Tacrolimus versus cyclosporine as primary immunosuppressant after renal transplantation: a meta-analysis and economics evaluation. Am J Ther. 2016;23(3):e810–e824.
   Web of Science ®Google Scholar
• Azzi JR, Sayegh MH, Mallat SG. Calcineurin inhibitors: 40 years later, can’t live without. J Immunol. 2013;191(12):5785–5791.
   PubMed Web of Science ®Google Scholar
• Almeida CC, Silveira MR, de Araújo VE, et al. Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis. Pharmaceuticals (Basel). 2013;6(10):1170–1194.
   PubMedGoogle Scholar
• Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005;331(7520):810.
   PubMed Web of Science ®Google Scholar
• El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9(3):527–535.
   PubMed Web of Science ®Google Scholar
• Pirsch JD, Miller J, Deierhoi MH, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation. 1997;63(7):977–983.
   PubMed Web of Science ®Google Scholar
• Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378–383.
   PubMed Web of Science ®Google Scholar
• Guerra AA, Cesar CC, Cherchiglia ML, et al. Cyclosporine versus tacrolimus in immunosuppressive maintenance regimens in renal transplants in Brazil: survival analysis from 2000 to 2004. Ann Pharmacother. 2010;44(1):192–201.
   PubMed Web of Science ®Google Scholar
• Guerra Júnior AA, Silva GD, Andrade EI, et al. Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil. Rev Saude Publica. 2015;49:1–9.
   PubMed Web of Science ®Google Scholar
• Coeli CM, Camargo K Jr. Avaliação de diferentes estratégias de blocagem no relacionamento probabilístico de registros. Rev Bras Epidemiol. 2002;5(2):185–196.
   Google Scholar
• Cherchiglia ML, Guerra Júnior AA, Andrade EIG, et al. A construção da base de dados nacional em terapia renal substitutiva (TRS) centrada no indivíduo: aplicação do método de linkage determinístico-probabilístico. Revista Brasileira de Estudos de População. 2007;24(1):163.
   Google Scholar
• Guerra Junior AA, Acúrcio FA, Andrade EI, et al. Ciclosporina versus tacrolimus no transplante renal no Brasil: uma comparação de custos. Cadernos de Saúde Pública. 2010;26(1):163–174.
   PubMed Web of Science ®Google Scholar
• Acúrcio FA, Brandão CMR, Guerra Júnior AA, et al. Perfil demográfico e epidemiológico dos usuários de medicamentos de alto custo no Sistema Único de Saúde; Perfil demográfico y epidemiológico de los usuarios de medicamentos de costo elevado en el Sistema Único de Salud. Rev Bras Estud Popul. 2009;26(2):263–282.
   Google Scholar
• Soylu H, Oruc M, Demirkol OK, et al. Survival of renal transplant patients: data from a tertiary care center in Turkey. Transplant Proc. 2015;47(2):348–353.
   PubMed Web of Science ®Google Scholar
• Harada KM, Mandia-Sampaio EL, de Sandes-Freitas TV, et al. Risk factors associated with graft loss and patient survival after kidney transplantation. Transplant Proc. 2009;41(9):3667–3670.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. 2009. IDF diabetes atlas. 4th ed. Brussels (Belgium): International Diabetes Federation. http://www.idf.org/media/press-materials/diabetes-data
   Google Scholar
• Cherchiglia ML, Machado EL, Szuster DAC, et al. Perfil epidemiológico dos pacientes em terapia renal substitutiva no Brasil, 2000–2004. Ver Saúde Pública. 2010;44(4):639–649.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Hickson LJ, Griffin MD, et al. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant. 2008;8(3):593–599.
   PubMed Web of Science ®Google Scholar
• Chen PD, Tsai MK, Lee CY, et al. Gender differences in renal transplant graft survival. J Formos Med Assoc. 2013;112(12):783–788.
   PubMed Web of Science ®Google Scholar
• Zhou JY, Cheng J, Huang HF, et al. The effect of donor-recipient gender mismatch on short- and long-term graft survival in kidney transplantation: a systematic review and meta-analysis. Clin Transplant. 2013;27(5):764–771.
   PubMed Web of Science ®Google Scholar
• Traynor C, Jenkinson A, Williams Y, et al. Twenty-year survivors of kidney transplantation. Am J Transplant. 2012;12(12):3289–3295.
   PubMed Web of Science ®Google Scholar
• Santiago EVA, Silveira MR, Araújo VE, et al. Gender in the allocation of organs in kidney transplants: meta-analysis. Rev Saúde Pública. 2015;49:68. [Epub ahead of print]
   Google Scholar
• Machado EL, Cherchiglia ML, Acúrcio F. [Profile and clinical outcome of patients in waiting list for kidney transplantation, Belo Horizonte (MG, Brazil), 2000–2005]. Cien Saude Colet. 2011;16(3):2373–2382.
   PubMed Web of Science ®Google Scholar
• Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 2002;62(1):311–318.
   PubMed Web of Science ®Google Scholar
• Kostakis ID, Moris DN, Barlas A, et al. Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases. Clin Transplant. 2013;27(6):838–843.
   PubMed Web of Science ®Google Scholar
• Rodelo JR, Nieto-Ríos JF, Serna-Higuita LM, et al. Survival of renal transplantation patients older than 60 years: a single-center experience. Transplant Proc. 2013;45(4):1402–1409.
   PubMed Web of Science ®Google Scholar
• Gill JS, Tonelli M, Johnson N, et al. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int. 2005;68(5):1161–1170.
   PubMed Web of Science ®Google Scholar
• Bunnapradist S, Daswani A, Takemoto SK. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. Transplantation. 2003;76(1):10–15.
   PubMed Web of Science ®Google Scholar
• Opelz G, Döhler B, Study CT. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Transplantation. 2009;87(6):795–802.
   PubMed Web of Science ®Google Scholar
• Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol. 2003;14(11):S290–6.
   Google Scholar
• Alghamdi S, Nabi Z, Skolnik E, et al. Cyclosporine versus tacrolimus maintenance therapy in renal transplant. Exp Clin Transplant. 2011;9(3):170.
   PubMed Web of Science ®Google Scholar